Clinical outcome predictors for metastatic renal cell carcinoma: a retrospective multicenter real-life case series

Clinical outcome predictors for metastatic renal cell carcinoma: a retrospective multicenter real-life case series

Abstract Over the last decades, the therapeutic armamentarium of metastatic renal cell carcinoma (mRCC) has been revolutionized by the advent of tyrosin-kinase inhibitors (TKI), immune-checkpoint inhibitors (ICI), and immune-combinations. RCC is heterogeneous, and even the most used validated progno...

Full description

Bibliographic Details
Main Authors: Mimma Rizzo, Gaetano Pezzicoli, Valentina Tibollo, Andrea Premoli, Silvana Quaglini
Format: Article
Language:English
Published: BMC 2024-07-01
Series:BMC Cancer
Subjects:
Renal cell carcinoma
Prognosis
Real-world data
Targeted therapy
Immunotherapy
Online Access:https://doi.org/10.1186/s12885-024-12572-4

Internet

https://doi.org/10.1186/s12885-024-12572-4

Similar Items